Tivic Health Registers 956K Shares for Resale by Investor, Enabling Access to $50M Equity Line

summarizeSummary

This prospectus supplement operationalizes the S-1 registration filed two days prior, making 956,222 shares available for resale by Tumim Stone Capital. While the company itself will not receive proceeds from these specific resales, this filing enables access to a larger $50.0 million equity line of credit, allowing Tivic Health to sell shares to Tumim at a discount (95-97% of VWAP). This financing is critical given the company's nano-cap status and the 'going concern' warning noted in its incorporated financial statements. The potential dilution from the currently registered shares is substantial, representing approximately 24.94% of the total outstanding common stock if fully issued, and the full $50 million facility could lead to even greater dilution. This indicates a significant need for capital, albeit on terms that are highly dilutive for existing shareholders.

check_boxKey Events

• Shares Registered for Resale

  Tivic Health Systems registered 956,222 shares of common stock for resale by Tumim Stone Capital, LLC. These shares include 519,210 shares the company may sell to Tumim and 437,012 shares issuable from a pre-funded warrant.

• Substantial Potential Dilution

  If all 956,222 shares were issued, they would represent approximately 24.94% of the total outstanding common stock, indicating significant dilution for existing shareholders.

• Access to $50 Million Equity Line

  This filing enables the company to sell up to $50.0 million in shares to Tumim Stone Capital over 24 months, at a discount of 3-5% to the volume-weighted average price (VWAP).

• Going Concern Warning

  The company's auditor's report, incorporated by reference, includes an explanatory paragraph expressing substantial doubt about Tivic Health Systems' ability to continue as a going concern.

auto_awesomeAnalysis

This prospectus supplement operationalizes the S-1 registration filed two days prior, making 956,222 shares available for resale by Tumim Stone Capital. While the company itself will not receive proceeds from these specific resales, this filing enables access to a larger $50.0 million equity line of credit, allowing Tivic Health to sell shares to Tumim at a discount (95-97% of VWAP). This financing is critical given the company's nano-cap status and the 'going concern' warning noted in its incorporated financial statements. The potential dilution from the currently registered shares is substantial, representing approximately 24.94% of the total outstanding common stock if fully issued, and the full $50 million facility could lead to even greater dilution. This indicates a significant need for capital, albeit on terms that are highly dilutive for existing shareholders.